QQQ   435.33 (-0.52%)
AAPL   180.39 (-1.23%)
MSFT   406.74 (-0.18%)
META   486.51 (-0.11%)
GOOGL   135.75 (-2.25%)
AMZN   173.62 (+0.05%)
TSLA   203.02 (+1.65%)
NVDA   783.58 (-0.44%)
NIO   5.49 (-5.02%)
AMD   176.09 (-1.07%)
BABA   75.03 (-3.41%)
T   17.01 (+1.07%)
F   12.33 (+2.75%)
MU   89.60 (-2.45%)
CGC   3.44 (-2.55%)
GE   155.29 (+0.84%)
DIS   110.94 (+1.39%)
AMC   4.94 (+2.70%)
PFE   27.14 (+0.93%)
PYPL   60.35 (+0.32%)
XOM   104.34 (+0.30%)
QQQ   435.33 (-0.52%)
AAPL   180.39 (-1.23%)
MSFT   406.74 (-0.18%)
META   486.51 (-0.11%)
GOOGL   135.75 (-2.25%)
AMZN   173.62 (+0.05%)
TSLA   203.02 (+1.65%)
NVDA   783.58 (-0.44%)
NIO   5.49 (-5.02%)
AMD   176.09 (-1.07%)
BABA   75.03 (-3.41%)
T   17.01 (+1.07%)
F   12.33 (+2.75%)
MU   89.60 (-2.45%)
CGC   3.44 (-2.55%)
GE   155.29 (+0.84%)
DIS   110.94 (+1.39%)
AMC   4.94 (+2.70%)
PFE   27.14 (+0.93%)
PYPL   60.35 (+0.32%)
XOM   104.34 (+0.30%)
QQQ   435.33 (-0.52%)
AAPL   180.39 (-1.23%)
MSFT   406.74 (-0.18%)
META   486.51 (-0.11%)
GOOGL   135.75 (-2.25%)
AMZN   173.62 (+0.05%)
TSLA   203.02 (+1.65%)
NVDA   783.58 (-0.44%)
NIO   5.49 (-5.02%)
AMD   176.09 (-1.07%)
BABA   75.03 (-3.41%)
T   17.01 (+1.07%)
F   12.33 (+2.75%)
MU   89.60 (-2.45%)
CGC   3.44 (-2.55%)
GE   155.29 (+0.84%)
DIS   110.94 (+1.39%)
AMC   4.94 (+2.70%)
PFE   27.14 (+0.93%)
PYPL   60.35 (+0.32%)
XOM   104.34 (+0.30%)
QQQ   435.33 (-0.52%)
AAPL   180.39 (-1.23%)
MSFT   406.74 (-0.18%)
META   486.51 (-0.11%)
GOOGL   135.75 (-2.25%)
AMZN   173.62 (+0.05%)
TSLA   203.02 (+1.65%)
NVDA   783.58 (-0.44%)
NIO   5.49 (-5.02%)
AMD   176.09 (-1.07%)
BABA   75.03 (-3.41%)
T   17.01 (+1.07%)
F   12.33 (+2.75%)
MU   89.60 (-2.45%)
CGC   3.44 (-2.55%)
GE   155.29 (+0.84%)
DIS   110.94 (+1.39%)
AMC   4.94 (+2.70%)
PFE   27.14 (+0.93%)
PYPL   60.35 (+0.32%)
XOM   104.34 (+0.30%)
NASDAQ:MDCO

Medicines (MDCO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$84.90
$84.90
50-Day Range
$84.90
$84.90
52-Week Range
$17.81
$84.98
Volume
N/A
Average Volume
9.55 million shs
Market Capitalization
$6.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MDCO stock logo

About Medicines Stock (NASDAQ:MDCO)

The Medicines Company, a biopharmaceutical company, focuses on developing therapeutics for the treatment of therosclerotic cardiovascular disease. The company is developing Inclisiran, an investigational RNA interference therapeutic that inhibits production of proprotein convertase subtilisin/kexin type 9, which controls LDL-cholesterol levels. It has collaboration agreement with Alnylam Pharmaceuticals, Inc. The Medicines Company was founded in 1996 and is headquartered in Parsippany, New Jersey.


MDCO Stock News Headlines

Medicine in Britain, c.1250 to the present day
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Warming on cancer risk in Chinese medicines
Gene modified chickens 'lay medicines'
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Does Pet Insurance Cover Medication?
See More Headlines
Receive MDCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicines and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/30/2019
Today
2/28/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MDCO
CUSIP
58468810
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

Net Income
$-123,160,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.14 million
Book Value
($0.30) per share

Miscellaneous

Free Float
N/A
Market Cap
$6.77 billion
Optionable
Optionable
Beta
1.10
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Mark Timney (Age 54)
    CEO & Director
  • Mr. Christopher J. Visioli (Age 43)
    CFO & Treasurer
  • Mr. Stephen M. Rodin J.D. (Age 43)
    Exec. VP, Gen. Counsel & Sec.
  • Dr. Clive A. Meanwell (Age 61)
    Chief Innovation Officer & Director
  • Dr. Goutham Krishna Gorti
    VP & Head of Investor Relations














MDCO Stock Analysis - Frequently Asked Questions

How were Medicines' earnings last quarter?

The Medicines Company (NASDAQ:MDCO) released its earnings results on Wednesday, October, 30th. The company reported ($0.92) earnings per share for the quarter, missing analysts' consensus estimates of ($0.80) by $0.12. During the same period last year, the firm posted ($0.70) earnings per share.

What other stocks do shareholders of Medicines own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicines investors own include Micron Technology (MU), NVIDIA (NVDA), AbbVie (ABBV), Gilead Sciences (GILD), Alibaba Group (BABA), Salesforce (CRM), Bank of America (BAC), Ionis Pharmaceuticals (IONS), AT&T (T) and Alnylam Pharmaceuticals (ALNY).

This page (NASDAQ:MDCO) was last updated on 2/28/2024 by MarketBeat.com Staff